Abbott Laboratories logo
Abbott Laboratories (ABT)
Compare

Abbott Laboratories (ABT) Earnings Yield: 4.04%

Is Abbott Laboratories’s earnings yield high or low?

Abbott Laboratories's earnings yield of 4.04% is in line with its 5-year average of 3.87%, around the middle of its 5-year range (2.47%–7.52%).

The earnings yield for Abbott Laboratories (ABT) is 4.04% as of Wednesday, June 10, 2026. It is below its 12-month average by 26.54% (5.50%).

ABT Earnings Yield Chart

ABT Earnings Yield
4.04%-29.74% 1Y
Zoom

ABT Average Earnings Yield Chart

ABT Current vs Average Earnings Yield Chart

ABT Earnings Yield Metrics

EARNINGS YIELD

4.04%

EARNINGS YIELD AVG TTM

5.50%

EARNINGS YIELD AVG 3Y

4.05%

EARNINGS YIELD AVG 5Y

3.87%

EARNINGS YIELD AVG 10Y

2.87%

EARNINGS YIELD AVG 15Y

4.47%

EARNINGS YIELD AVG 20Y

6.04%

CURRENT VS TTM AVG

-26.54%

CURRENT VS 3Y AVG

-0.31%

CURRENT VS 5Y AVG

+4.42%

CURRENT VS 10Y AVG

+40.87%

CURRENT VS 15Y AVG

-9.62%

CURRENT VS 20Y AVG

-33.08%

ABT Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
Abbott Laboratories (ABT)$154.66B4.04%5.50%4.05%3.87%
Gilead Sciences, Inc. (GILD)$151.21B6.03%4.73%3.68%4.37%
Intuitive Surgical, Inc. (ISRG)$146.44B1.99%1.54%1.36%1.43%
Pfizer Inc. (PFE)$146.36B5.11%6.28%6.38%7.46%
Danaher Corporation (DHR)$130.25B2.80%2.43%2.72%3.03%
Thermo Fisher Scientific Inc. (TMO)$179.45B3.77%3.47%3.14%3.26%
Amgen Inc. (AMGN)$183.75B4.22%4.01%3.83%4.18%
CVS Health Corporation (CVS)$125.16B2.31%2.92%5.90%5.70%
Bristol-Myers Squibb Company (BMY)$114.14B6.37%5.69%6.24%5.43%
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B3.86%3.40%3.43%3.73%

Earnings Yield vs P/E Ratio

Earnings Yield

4.04%

EPS ÷ Price

P/E Ratio

24.7

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Abbott Laboratories Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Abbott Laboratories Earnings Yield FAQ

What is the earnings yield for Abbott Laboratories (ABT)?
The earnings yield for ABT stock is 4.04%.
Is Abbott Laboratories's earnings yield high or low?
Abbott Laboratories's earnings yield of 4.04% is in line with its 5-year average of 3.87%, around the middle of its 5-year range (2.47%–7.52%).
What is the TTM average earnings yield for Abbott Laboratories (ABT)?
The TTM average earnings yield for ABT stock is 5.50%.
What is the 3Y average earnings yield for Abbott Laboratories (ABT)?
The 3Y average earnings yield for ABT stock is 4.05%.
What is the 5Y average earnings yield for Abbott Laboratories (ABT)?
The 5Y average earnings yield for ABT stock is 3.87%.
What is the 10Y average earnings yield for Abbott Laboratories (ABT)?
The 10Y average earnings yield for ABT stock is 2.87%.
What is the 15Y average earnings yield for Abbott Laboratories (ABT)?
The 15Y average earnings yield for ABT stock is 4.47%.
What is the 20Y average earnings yield for Abbott Laboratories (ABT)?
The 20Y average earnings yield for ABT stock is 6.04%.

Abbott Laboratories Earnings Yield History

DATEEARNINGS YIELD
2026-06-104.04%
2026-06-093.93%
2026-06-083.97%
2026-06-053.94%
2026-06-043.95%
2026-06-034.13%
2026-06-024.13%
2026-06-014.09%
2026-05-294.19%
2026-05-284.16%
2026-05-274.19%
2026-05-264.14%
2026-05-224.11%
2026-05-214.09%
2026-05-204.06%
2026-05-194.04%
2026-05-184.08%
2026-05-154.25%
2026-05-144.23%
2026-05-134.28%
2026-05-124.26%
2026-05-114.35%
2026-05-084.26%
2026-05-074.13%
2026-05-064.16%
2026-05-054.12%
2026-05-044.10%
2026-05-014.01%
2026-04-303.95%
2026-04-293.93%
2026-04-283.97%
2026-04-274.02%
2026-04-244.09%
2026-04-234.03%
2026-04-224.07%
2026-04-214.02%
2026-04-203.88%
2026-04-173.85%
2026-04-163.90%
2026-04-153.67%
2026-04-143.69%
2026-04-133.70%
2026-04-103.72%
2026-04-093.63%
2026-04-083.60%
2026-04-073.66%
2026-04-063.64%
2026-04-023.62%
2026-04-013.64%
2026-03-313.63%
2026-03-303.66%
2026-03-273.59%
2026-03-263.57%
2026-03-253.56%
2026-03-243.58%
2026-03-233.56%
2026-03-203.53%
2026-03-193.48%
2026-03-183.44%
2026-03-173.37%
2026-03-163.39%
2026-03-133.45%
2026-03-123.45%
2026-03-113.38%
2026-03-103.37%
2026-03-093.31%
2026-03-063.40%
2026-03-053.36%
2026-03-043.30%
2026-03-033.28%
2026-03-023.27%
2026-02-273.20%
2026-02-263.21%
2026-02-253.25%
2026-02-243.25%
2026-02-233.23%
2026-02-203.32%
2026-02-197.11%
2026-02-187.04%
2026-02-177.11%
2026-02-137.08%
2026-02-127.16%
2026-02-117.02%
2026-02-107.11%
2026-02-097.18%
2026-02-067.20%
2026-02-057.32%
2026-02-047.37%
2026-02-037.32%
2026-02-027.29%
2026-01-307.30%
2026-01-297.52%
2026-01-287.52%
2026-01-277.37%
2026-01-267.34%
2026-01-237.43%
2026-01-227.35%
2026-01-216.61%
2026-01-206.59%
2026-01-166.55%
2026-01-156.46%
2026-01-146.38%
2026-01-136.42%
2026-01-126.40%
2026-01-096.34%
2026-01-086.32%
2026-01-076.28%
2026-01-066.24%
2026-01-056.31%
2026-01-026.42%
2025-12-316.37%
2025-12-306.34%
2025-12-296.41%
2025-12-266.39%
2025-12-246.39%
2025-12-236.41%
2025-12-226.37%
2025-12-196.36%
2025-12-186.38%
2025-12-176.30%
2025-12-166.29%
2025-12-156.21%
2025-12-126.36%
2025-12-116.47%
2025-12-106.51%
2025-12-096.58%
2025-12-086.54%
2025-12-056.38%
2025-12-046.36%
2025-12-036.37%
2025-12-026.32%
2025-12-016.23%
2025-11-286.19%
2025-11-266.21%
2025-11-256.23%
2025-11-246.27%
2025-11-216.23%
2025-11-206.44%
2025-11-196.33%
2025-11-186.14%
2025-11-176.13%
2025-11-146.11%
2025-11-136.17%
2025-11-126.19%
2025-11-116.28%
2025-11-106.34%
2025-11-076.31%
2025-11-066.39%
2025-11-056.41%
2025-11-046.34%
2025-11-036.44%
2025-10-316.46%
2025-10-306.40%
2025-10-296.41%
2025-10-286.30%
2025-10-276.27%
2025-10-246.29%
2025-10-236.31%
2025-10-226.23%
2025-10-216.25%
2025-10-206.16%
2025-10-176.21%
2025-10-166.25%
2025-10-156.16%
2025-10-145.99%
2025-10-136.07%
2025-10-106.02%
2025-10-095.98%
2025-10-085.94%
2025-10-076.00%
2025-10-065.97%
2025-10-035.93%
2025-10-026.00%
2025-10-015.98%
2025-09-305.96%
2025-09-296.00%
2025-09-265.97%
2025-09-255.98%
2025-09-245.96%
2025-09-235.87%
2025-09-225.84%
2025-09-195.87%
2025-09-185.93%
2025-09-175.95%
2025-09-166.01%
2025-09-156.08%
2025-09-125.97%
2025-09-116.01%
2025-09-106.17%
2025-09-096.05%
2025-09-086.04%
2025-09-056.00%
2025-09-046.01%
2025-09-036.04%
2025-09-026.07%
2025-08-296.01%
2025-08-286.07%
2025-08-276.07%
2025-08-266.06%
2025-08-256.05%
2025-08-226.02%
2025-08-216.05%
2025-08-206.02%
2025-08-196.08%
2025-08-186.12%
2025-08-156.06%
2025-08-146.17%
2025-08-136.17%
2025-08-126.09%
2025-08-116.08%
2025-08-085.94%
2025-08-076.04%
2025-08-066.09%
2025-08-056.11%
2025-08-046.14%
2025-08-016.27%
2025-07-316.32%
2025-07-306.21%
2025-07-296.02%
2025-07-286.10%
2025-07-256.09%
2025-07-246.13%
2025-07-236.13%
2025-07-226.13%
2025-07-216.20%
2025-07-186.23%
2025-07-176.40%
2025-07-165.85%
2025-07-155.86%
2025-07-145.84%
2025-07-115.84%
2025-07-105.77%
2025-07-095.79%
2025-07-085.78%
2025-07-075.77%
2025-07-035.73%
2025-07-025.75%
2025-07-015.66%
2025-06-305.67%
2025-06-275.74%
2025-06-265.77%
2025-06-255.61%
2025-06-245.58%
2025-06-235.78%
2025-06-205.80%
2025-06-185.82%
2025-06-175.83%
2025-06-165.75%
2025-06-135.69%
2025-06-125.65%
2025-06-115.70%
2025-06-105.75%
2025-06-095.78%
2025-06-065.77%
2025-06-055.75%
2025-06-045.80%
2025-06-035.76%
2025-06-025.77%
2025-05-305.77%
2025-05-295.80%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL
114,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford